ScreenerHero

VRPX Virpax Pharmaceuticals, Inc.

Partial data
NAS · US · Healthcare · Biotechnology · virpaxpharma.com
0.0111USD+11000.00%Mkt Cap: 13791 $P/E: —

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatment…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap13.79K USD
Enterprise Value-1.35M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.07M USD
Revenue/Share—
Last Price0.0111 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)-71.00
EPS (Forward)-0.90
52W Range
0.000111% of range0.1000
52W High0.1000 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1320.61%
ROA-775.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.71M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-88902.02%
Net Debt-1.51M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.63
Quick Ratio0.61
Book Value/Sh-1.53 USD
Cash/Share1.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateMar 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.24M
Float1.05M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Float1.81%
Short % Out.1.81%
Shares Short23.08K
Short (prev mo.)62.88K
Technical
SMA 500.0025 (+338.0%)
SMA 2000.0057 (+93.7%)
Beta-16.52
S&P 52W Chg14.16%
Avg Vol (30d)393
Avg Vol (10d)0
Technical Indicators
RSI (14)93.4
MACD0.0004
MACD Signal-0.0005
MACD Hist.+0.0009
BB Upper0.0056 USD
BB Middle0.0007 USD
BB Lower-0.0042 USD
BB Width1465.85%
ATR (14)0.0017 USD
Vol Ratio (20d)0.00x